Scientists test drug to block Cocaine's high
NCT ID NCT06273540
Summary
This early-stage study tested whether a new oral medicine called STP7 (mavoglurant) changes how the body reacts to cocaine. Researchers gave 21 adults with cocaine use disorder either the medicine or a placebo, along with controlled doses of intravenous cocaine. The main goal was to check for safety issues and see if the medicine changed cocaine's effects on the heart, blood pressure, and how people felt.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCAINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical Kansas
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.